MLS-2384 is a dual JAK/Src kinase inhibitor, suppressing growth of diverse cancer cells. References: Liu L, Gaboriaud N, Vougogianopoulou K, Tian Y, Wu J, Wen W, Skaltsounis L, Jove R. MLS-2384, a new 6-bromoindirubin derivative with dual JAK/Src kinase inhibitory activity, suppresses growth of diverse cancer cells. Cancer Biol Ther. 2014 Feb;15(2):178-84. doi: 10.4161/cbt.26721. Epub 2013 Nov 1. PubMed PMID: 24100507; PubMed Central PMCID: PMC3928133.

纯度：≥98%

CAS：1067884-45-0